ANRO
Alto Neuroscience, Inc.
+0.68 (+2.28%)30.69USD92.8K成交股數1.2B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 22.1M | 20.3M | 12.0M | 10.5M | 13.1M | 10.0M | 13.1M | 13.2M | 10.0M | 9.6M | 8.0M | 7.1M |
| 銷售管理費用 | 7.0M | 6.8M | 5.1M | 4.4M | 5.6M | 5.7M | 5.8M | 5.2M | 4.4M | 2.1M | 1.8M | 2.1M |
| 營業利益 | −29.1M+56% | −27.1M+73% | −17.1M-10% | −15.0M-18% | −18.7M+30% | −15.7M+33% | −18.9M+94% | −18.3M+101% | −14.4M | −11.8M | −9.7M | −9.1M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −27.6M+56% | −26.2M+73% | −16.2M-4% | −14.2M-12% | −17.7M+32% | −15.2M+35% | −16.8M+84% | −16.0M+85% | −13.4M | −11.2M | −9.1M | −8.7M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.650% | -0.80+43% | -0.46-26% | -0.52-13% | -0.65-14% | -0.56-81% | -0.62-75% | -0.60-74% | -0.76 | -2.99 | -2.44 | -2.33 |
| 稀釋股數 | 42.8M | 32.9M | 28.9M | 27.1M | 27.1M | 27.0M | 27.0M | 26.9M | 17.6M | 3.7M | 3.7M | 3.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 244M | 264M | 176M | 138M | 148M | 161M | 182M | 193M | 206M | 82.5M | 51.3M | 59.0M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 254M | 276M | 185M | 147M | 158M | 172M | 192M | 197M | 210M | 86.6M | – | – |
| 有息負債 | 12.4M | 13.9M | 16.2M | 20.3M | 20.1M | 19.9M | 6.6M | 7.7M | 8.8M | 9.9M | – | – |
| 總負債 | 34.8M | 32.9M | 33.5M | 35.4M | 34.5M | 32.8M | 26.6M | 17.6M | 16.8M | 16.8M | – | – |
| 股東權益 | 219M | 243M | 151M | 112M | 123M | 139M | 165M | 180M | 193M | −71.7M | −61.1M | −52.6M |
| 負債比 | 13.7% | 11.9% | 18.2% | 24.1% | 21.8% | 19.1% | 13.9% | 8.9% | 8.0% | 19.4% | – | – |
| 淨現金(現金 − 有息負債) | 231M | 250M | 160M | 118M | 127M | 141M | 175M | 185M | 197M | 72.7M | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −27.1M+64% | – | – | – | −16.6M | – | – | −11.0M | – | – | – |
| 資本支出 | – | 556K | – | – | – | 24K | – | – | 224K | – | – | – |
| 自由現金流 | – | −27.6M+67% | – | – | – | −16.6M | – | – | −11.2M | – | – | – |
| 折舊攤銷 | – | – | – | – | 100K | 171K | 200K | 100K | 97K | 87K | 100K | 100K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −63.2M | –% | -2.19 | −51.8M |
| FY2024 | – | – | −61.4M | –% | -2.50 | −49.5M |
| FY2023 | – | – | −36.3M | –% | -9.73 | −33.9M |